Wearable full-body motion tracking of activities of daily living predicts disease trajectory in Duchenne muscular dystrophy. (2023)

First Author: Ricotti V
Attributed to:  Applying epigenetic modifying drugs to treat Friedreich's Ataxia funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41591-022-02045-1

PubMed Identifier: 36658421

Publication URI: http://europepmc.org/abstract/MED/36658421

Type: Journal Article/Review

Volume: 29

Parent Publication: Nature medicine

Issue: 1

ISSN: 1078-8956